Title:
USES OF DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES
Document Type and Number:
WIPO Patent Application WO/2023/053272
Kind Code:
A1
Abstract:
The disclosure provides uses of multispecific antigen-binding molecules that targets human DLL3 for the treatment of cancers.
Inventors:
NAOI SOTARO (JP)
FENG SHU (SG)
IGAWA TOMOYUKI (JP)
HO SHU WEN SAMANTHA (SG)
MATSUDA YUTAKA (JP)
MIKAMI HIROFUMI (JP)
KAWAI YUMIKO (JP)
TSUNENARI TOSHIAKI (JP)
FENG SHU (SG)
IGAWA TOMOYUKI (JP)
HO SHU WEN SAMANTHA (SG)
MATSUDA YUTAKA (JP)
MIKAMI HIROFUMI (JP)
KAWAI YUMIKO (JP)
TSUNENARI TOSHIAKI (JP)
Application Number:
PCT/JP2021/035877
Publication Date:
April 06, 2023
Filing Date:
September 29, 2021
Export Citation:
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K39/395; A61K31/4745; A61K31/704; A61K31/7048; A61K33/245; A61K45/00; A61P35/00; A61P43/00
Domestic Patent References:
WO2020067399A1 | 2020-04-02 | |||
WO2019131988A1 | 2019-07-04 | |||
WO2020067419A1 | 2020-04-02 |
Foreign References:
JP2021159081A | 2021-10-11 |
Attorney, Agent or Firm:
HARUNA, Masao et al. (JP)
Download PDF: